Actions of 8-Epi prostaglandin F2α on isolated rat aorta

被引:13
作者
Kromer, BM [1 ]
Tippins, JR [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England
关键词
isoprostane; ischaemia; oxidant stress; coronary artery disease;
D O I
10.1097/00005344-199809000-00019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
8-Epi prostaglandin F-2 alpha (8-epi PGF(2 alpha)) contracted rat thoracic aorta rings in a concentration-dependent manner in the presence or absence of functional endothelium [median effective concentration (EC50) values, 455 +/- 52 and 268 +/- 34 nM, respectively; Student's t test; p = 0.006]. U46619 was a more potent agonist with or without functional endothelium (EC50 values, 6.8 +/- 1.6 and 4.5 +/- 1.0 nM, respectively). SQ29548 [a thromboxane (TP)-receptor antagonist] inhibited contractions to both 8-epi PGF(2 alpha) and U46619 in a competitive manner, with mean pA(2) values of 8.3 and 7.9, respectively. 8-Epi PGF(2 alpha) had a further contractile effect in vessels that had been contracted with noradrenaline and had been shown to possess a functional endothelium. Inhibition of thromboxane synthesis with OKY-046 or blockade of endothelin receptors with bosentan had no effect on responses to 8-epi PGF(2 alpha) or U46619. Preincubation with 8-epi PGF(2 alpha) or noradrenaline shifted the concentration-response curves to U46619 upward at low concentrations of U46619 with no significant change in EC50 Values or maximal responses. Reduction of TP-receptor number in rat aorta with dithiothreitol caused a concentration-dependent inhibition of responses to both U46619 and 8-epi PGF(2 alpha), with no effect on maximal responses and or on the responses to U46619 after the preincubation with 8-epi PGF(2 alpha). These results indicate that 8-epi PGF(2 alpha) is a potent vasoconstrictor in the rat aorta and are suggestive of an action of 8-epi PGF(2 alpha) at the TP receptor.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 33 条
[1]   EFFECTS OF A NOVEL PROSTAGLANDIN, 8-EPI-PGF2-ALPHA, IN RABBIT LUNG INSITU [J].
BANERJEE, M ;
KANG, KH ;
MORROW, JD ;
ROBERTS, LJ ;
NEWMAN, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H660-H663
[2]  
Ciabattoni G, 1996, J INVEST MED, V44, pA269
[3]  
Cotton RB, 1996, PEDIATR RES, V39, P1957
[4]   8-Epi PGF(2 alpha) generation during coronary reperfusion - A potential quantitative marker of oxidant stress in vivo [J].
Delanty, N ;
Reilly, MP ;
Pratico, D ;
Lawson, JA ;
McCarthy, JF ;
Wood, AE ;
Ohnishi, ST ;
Fitzgerald, DJ ;
FitzGerald, GA .
CIRCULATION, 1997, 95 (11) :2492-2499
[5]  
DORN GW, 1990, J BIOL CHEM, V265, P4240
[6]  
FUKUNAGA M, 1995, J CARDIOVASC PHARM, V26, pS51
[7]   Evidence for the distinct nature of F-2-isoprostane receptors from those of thromboxane A(2) [J].
Fukunaga, M ;
Yura, T ;
Grygorczyk, R ;
Badr, KF .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 272 (04) :F477-F483
[8]   EVIDENCE FOR THE EXISTENCE OF F2-ISOPROSTANE RECEPTORS ON RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
FUKUNAGA, M ;
MAKITA, N ;
ROBERTS, LJ ;
MORROW, JD ;
TAKAHASHI, K ;
BADR, KF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :C1619-C1624
[9]   Prostaglandin F-2-like compounds, F-2-isoprostanes, are present in increased amounts in human atherosclerotic lesions [J].
Gniwotta, C ;
Morrow, JD ;
Roberts, LJ ;
Kuhn, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3236-3241
[10]  
Goil S, 1996, PEDIATR RES, V39, P1980